ADMA Biologics reported FY 2024 revenue of $426.5 million, achieving significant increases in net income and adjusted EBITDA. ADMA Biologics, Inc. reported strong financial results for FY 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback